BioLife Solutions, Inc. (BLFS) financial statements and ratios from SEC XBRL: revenue $96.21M (TTM), net margin -4.8%, revenue growth 14.9% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $96.21M |
| Net Margin | -4.8% |
| Revenue Growth (YoY) | 14.9% |
| EPS Growth (YoY) | -300.0% |
| FCF Growth (YoY) | -142.4% |
| Price / Book | 4.85 |
| Price / Sales | 18.10 |
| FCF Yield | -0.0% |
| DCF Value (model) | $1.70 |
| DCF Upside vs Price | -95.4% |
| Altman Z-Score | 31.16 (safe) |
| Piotroski F-Score | 6/9 |
| Sector P/E (Healthcare) | 21.6 |
BLFS overview · BLFS earnings · BLFS KPIs · BLFS investor relations · BLFS ownership · BLFS peers · BLFS filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.